Global market valuation was derived through revenue mapping and procedure volume analysis specific to wound care interventions. The methodology included:
Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America covering advanced wound care (moist dressings, antimicrobial dressings, alginate, hydrocolloid, foam, hydrogel), negative pressure wound therapy systems, hyperbaric oxygen therapy equipment, traditional wound care (gauze, bandages, tapes), sutures, and staplers
Product mapping across dressing categories, wound type applications (chronic vs. acute), and end-user settings (hospitals vs. residential care)
Analysis of reported and modeled annual revenues specific to wound care product portfolios, including disaggregation of consolidated company reporting to isolate wound management business units
Coverage of manufacturers representing 75-80% of global market share in 2024, including Smith & Nephew, 3M, Mölnlycke, Convatec, Coloplast, B. Braun, Hollister, Medtronic, and Acelity
Extrapolation using bottom-up (procedure volume × ASP by country for surgical wounds, diabetic foot ulcer treatments, pressure ulcer management, and burn care) and top-down (manufacturer revenue validation by product segment) approaches to derive segment-specific valuations for advanced wound care, traditional wound care, and active wound care segments